SCHEMBL803190

SCHEMBL803190

COC(=O)c1ccc2c(c1)[C@H](N(C)C(=O)c1ccccc1Cl)CC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
WDR5 P61964 1/20 0.42
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
PKM P14618 1/20 0.40
RAB9A P51151 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
KMT2A Q03164 2/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
ALDH1A1 P00352 3/20 0.38
ACHE P22303 2/20 0.38
LMNA P02545 1/20 0.38
SPR P35270 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13131593 1.00 HPGD (0.46) HPGDTSHRWDR5NPC1POLB
SCHEMBL803576 0.88 LMNA (0.40) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL785069 0.88 HPGD (0.49) HPGDTSHRPOLBTAS1R3TAS1R1
SCHEMBL484622 0.88 HPGD (0.49) HPGDTSHRPOLBTAS1R3TAS1R1
SCHEMBL803727 0.88 HPGD (0.40) HPGDNPC1RAB9ATRPM8SLC6A2
SCHEMBL803553 0.88 TRPM8 (0.39) TSHRKMT2AMEN1TRPM8SLC6A2
SCHEMBL13131594 0.88 WDR5 (0.41) HPGDTSHRWDR5NPC1POLB
SCHEMBL803219 0.87 WDR5 (0.41) HPGDTSHRWDR5NPC1POLB
SCHEMBL803508 0.87 WDR5 (0.41) HPGDTSHRWDR5NPC1POLB
SCHEMBL803189 0.87 TRPM8 (0.43) HPGDTSHRWDR5NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 HPGD 1082/4885TSHR 586/4885WDR5 2611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.